Source: Bloomberg | November 1, 2018 The U.S. patent system was designed to protect new innovations, but drugmakers are more often than not using it to protect old ones. At least 74 percent of drugs associated with new patents were medicines … Continue reading
Source: Fix the Patent Laws Intellectual property policy welcomed after nine years of development JOHANNESBURG, 31 MAY 2018 – Yesterday, after nine years of development, the Department of Trade and Industry (the dti) finally published the Intellectual Property Policy of the … Continue reading
Source: The Wire | May 27, 2018 New Delhi: Tragedies can be tipping points for change. And through their bereavements, four families have come together to demand accountability and change from the government as well as from private hospitals. They are … Continue reading
Source: Fix the Patent Laws | May 24, 2018 The Fix the Patent Laws Coalition (FTPL) welcomes the news today that the Cabinet of the Government of South Africa has approved the new Intellectual Property (IP) Policy. After nine years of … Continue reading
The recent report on “Pharmaceutical Patent Grants in India How our safeguards against evergreening have failed, and why the system must be reformed” shows immense irregularities in grant of patents in the country. Over the past decades India’s patent system has … Continue reading
Source: Business Today | April 25, 2018 Majority of pharmaceutical drug patents granted by India might have skipped elaborate scrutiny, an analysis of patent grants by a team of researchers and patent lawyers reveals. The report which studied the prosecution history of … Continue reading
Highlighting a new campaign aimed at the Scottish government on the price of Roche’s pertuzumab for breast cancer Dunise is a Scottish woman with breast cancer. Right now she is getting access to a drug pertuzumab (Perjeta) because she live in England.